Filter Results :

Your search for Antibodies returned 63 reports

Sort by


Global Antibodies Industry 2015 Market Research Report

13 Aug 2015  |  Published by:  QYResearch
The Global Antibodies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Antibodies industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Antibodies market...

$ 2,800.00

Read More

Global Biosimilar Monoclonal Antibodies Industry 2015 Market Research Report

13 Aug 2015  |  Published by:  QYResearch
The Global Biosimilar Monoclonal Antibodies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biosimilar Monoclonal Antibodies industry.The report provides a basic overview of the industry including definitions, classifications, applications and in...

$ 2,800.00

Read More

Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Product Pipelines, Trends, Key Players, Regulations and Strategic Outlook

01 Aug 2015  |  Published by:  Kelly Scientific Publications
Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost nearly $100,000 per patient per year. Thes...

$ 3,400.00

Read More

Global Monoclonal Antibodies Industry 2015 Market Research Report

17 Jul 2015  |  Published by:  9Dimen Research
2015 Global Monoclonal Antibodies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Monoclonal Antibodies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan ...

$ 2,850.00

Read More

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

16 Jul 2015  |  Published by:  MarketsandMarkets
Report Description Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of c...

$ 4,650.00

Read More

Global Breast Cancer Monoclonal Antibodies Market Outlook 2020

22 May 2015  |  Published by:  KuicK Research
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and eff...

$ 1,800.00

Read More

The 2016 Report on AntiCD20 Monoclonal Antibodies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

01 Apr 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of A...

$ 1,464.26

Read More

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

28 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloa...

$ 281.59

Read More

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

25 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated malignancies and rheumatoid arthritis as of March 2015. Purchase of...

$ 337.91

Read More

Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020

24 Mar 2015  |  Published by:  MarketsandMarkets
Report Description Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions. The report segments the global protein engineering market product, technology, pr...

$ 4,650.00

Read More

Competitor Analysis: TNF Antibodies 2015 - Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

22 Mar 2015  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence report about TNF Antibodies 2015 – Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflamma...

$ 563.18

Read More

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

17 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from com...

$ 135.16

Read More

Global Monoclonal Antibodies Pipeline Insight 2015

04 Mar 2015  |  Published by:  PNS Pharma
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with ...

$ 2,400.00

Read More

Competitor Analysis: Specific and Bispecific Her3 Antibodies

16 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant specific antibodies targeting Her3 or bispecific antibodies targeting Her3 and Her2 or EGF-R or other targets for treatment of cancer as of February 2...

$ 225.27

Read More
Total 63 records.